10X Capital Management, LLC, 10% Owner at GALECTIN THERAPEUTICS INC (GALT), sold 236,280 shares at $7.97 ($1.7M) on 2018-06-13, disclosed to the SEC on 2018-06-14.
Scheduled sale ($1.7M) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.59 | 60,000 | $395K | 23.0% |
| 2 | $7.09 | 60,000 | $425K | 24.8% |
| 3 | $7.47 | 60,000 | $448K | 26.1% |
| 4 | $7.97 | 28,140 | $224K | 13.1% |
| 5 | $7.97 | 28,140 | $224K | 13.1% |
| Total | $7.27 avg | 236,280 |
| $1.7M |
| 100% |
| Filing → |
| GALT | SELL | 2025-10-24 | $247K | — | Filing → |
| GALT | SELL | 2022-01-13 | $21K | — | Filing → |
| GALT | SELL | 2021-11-04 | $32K | — | Filing → |